» Articles » PMID: 37822078

Emergency Department Initiation of Pharmacotherapy for Alcohol Use Disorder: A Retrospective Cohort Study

Overview
Journal Acad Emerg Med
Publisher Wiley
Specialty Emergency Medicine
Date 2023 Oct 12
PMID 37822078
Authors
Affiliations
Soon will be listed here.
References
1.
Bouza C, Angeles M, Magro A, Munoz A, Amate J . Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction. 2004; 99(7):811-28. DOI: 10.1111/j.1360-0443.2004.00763.x. View

2.
Murphy 4th C, Coralic Z, Wang R, Montoy J, Ramirez B, Raven M . Extended-Release Naltrexone and Case Management for Treatment of Alcohol Use Disorder in the Emergency Department. Ann Emerg Med. 2022; 81(4):440-449. DOI: 10.1016/j.annemergmed.2022.08.453. View

3.
Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

4.
Punia K, Scott W, Manuja K, Sabbineni M, Campbell K, Balodis I . SAEM GRACE: Anti-craving medications for alcohol use disorder treatment in the emergency department: A systematic review of direct evidence. Acad Emerg Med. 2023; 31(5):504-514. DOI: 10.1111/acem.14806. View

5.
Anderson E, Chamberlin M, Zuluaga M, Ullal M, Hawk K, McCormack R . Implementation of Oral and Extended-Release Naltrexone for the Treatment of Emergency Department Patients With Moderate to Severe Alcohol Use Disorder: Feasibility and Initial Outcomes. Ann Emerg Med. 2021; 78(6):752-758. DOI: 10.1016/j.annemergmed.2021.05.013. View